From GlobeNewswire:

CRISPR Therapeutics will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024, at 2:15 p.m. PT in San Francisco. A webcast will be available at the Company’s website. Replays will be archived for 14 days following the presentation.

CRISPR Therapeutics is focused on developing transformative gene-based medicines for serious diseases using CRISPR/Cas9 technology. The company has established a portfolio of therapeutic programs in areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company is headquartered in Zug, Switzerland, with U.S. and U.K. offices.



Read more: CRISPR Therapeutics to Present at the 42nd Annual J.P.